This presentation will begin with a brief review of ocular surface disease, including definition, risk factors, and how to identify/diagnose. Followed by background on blepharitis (demodex), chalazion, and hordeolum. Particular emphasis will be placed on both 1) modern in-office therapeutic options (i.e. MBE, Thermal Expression, IPL, Amniotic Membrane) as well as 2) updated pharmaceutical options (ie immunomodulators, recently FDA-approved ophthalmic therapies, and new drugs in the pipeline). We will also discuss managing blepharitis with glaucoma patients. If time allows, we will cover Grand Rounds and patient cases.
Speaker: Dr. Vin Dang
![](https://i.ytimg.com/vi/74yO5hOVqeY/mqdefault.jpg)